<DOC>
	<DOCNO>NCT03082703</DOCNO>
	<brief_summary>This randomize study aim examine impact text message management non-alcoholic fatty liver disease ( NAFLD ) non-alcoholic steatohepatitis ( NASH ) , disease frequently associate obesity vary component metabolic syndrome include diabetes mellitus , hypertension , dyslipidemia . With rise incidence obesity US , NAFLD NASH rapidly increase currently second etiology liver transplantation US . The objective protocol ) prospectively enroll patient NAFLD NASH ; b ) randomize receive text message help manage obesity component od metabolic syndrome addition standard clinical care receive standard clinical care ; c ) follow patient end 3 month period weight loss , blood pressure control , HBA1c , liver enzymes . The immediate aim protocol develop pilot data usefulness text message management NAFLD NASH . The long-term goal research establish text message beneficial intervention management weight loss control risk factor NAFLD improve outcomes patient NAFLD NASH .</brief_summary>
	<brief_title>Impact Text Messaging Management Non-alcoholic Fatty Liver Disease</brief_title>
	<detailed_description>Patients recruit primarily outpatient Liver Kirklin Clinic setting . 1 . Informed consent obtain one investigator name protocol research coordinator involve study 2 . Eligibility confirm interview review medical record use inclusion exclusion criterion list . 3 . Complete history physical examination record especially weight body mass index , associate component metabolic syndrome ( diabetes , hypertension , dyslipidemia ) , liver enzymes , current medication list . 4 . All procedure image , endoscopy , liver biopsy do part standard routine care patient procedure do part research study . 5 . Patients would randomize standard clinical care text message addition standard clinical care . Standard clinical care include obtain data history physical examination , routine blood work part liver disease care , ultrasound appropriate liver image need patient care , counsel least 7-10 % weight loss discussion strategy achieve , management risk factor include diabetes , hypertension , dyslipidemia , counsel compliance take medication follow future clinic visit . The study investigator would blind randomization group patient randomize . 6 . Patients would follow end 6 month period assess study outcome detail earlier . Follow patient stable liver disease usually do every 3-6 month . No additional clinic visit would need study . 7 . During 6 month , patient would receive standard text message detail later . Patients use cell phone receive text message reply message . There additional intervention device need study</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>1 . Patients diagnosis NAFLD NASH determine presence steatosis and/or elevate liver enzymes , exclusion cause liver disease , history alcohol use le 10 g/d . 2 . Age &gt; 18 year 3 . Established patient UAB Kirklin clinic least 36 month 4 . Ownership cell phone text message service 5 . Ability read send text message 1 . Failure meet inclusion criterion . 2 . Any medical , psychiatric , social condition , opinion investigator , would make participation protocol best interest subject 3 . Refusal consent study 4 . Pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>